Medical test developer BiologyWorks reported on Tuesday the addition of Hunt Ramsbottom as its chief executive officer.
The company said Ramsbottom's appointment is in connection with the launch its molecular testing solution to commercial market this year. It delivers PCR-level results in minutes for COVID-19, Influenza A/B, Hepatitis B, Streptococcus, STDs, AIDS/HIV and Pneumonia.
Prior to joining the company, Ramsbottom has served as chief executive officer for six public and private companies.
Ramsbottom brings with him more than 25 years of experience leading technology and manufacturing firms. He has raised over USD2.5bn and led acquisitions of over 70 companies while driving organic growth, concluded the company.
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus
Seres Therapeutics provides business updates and reports Q2 2023 financial results